The University of Chicago Header Logo
Last Name



This is a "connection" page, showing publications co-authored by Mark Talamonti and Michael Ujiki.

Connection Strength
  1. Ujiki MB, Talamonti MS. Guidelines for the surgical management of pancreatic adenocarcinoma. Semin Oncol. 2007 Aug; 34(4):311-20.
    View in: PubMed
    Score: 0.349
  2. Ujiki MB, Talamonti MS. Surgical management of pancreatic cancer. Semin Radiat Oncol. 2005 Oct; 15(4):218-25.
    View in: PubMed
    Score: 0.308
  3. Brown CS, Lapin B, Goldstein JL, Linn JG, Talamonti MS, Carbray J, Ujiki MB. Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score). Ann Surg. 2018 04; 267(4):716-720.
    View in: PubMed
    Score: 0.183
  4. Vigneswaran Y, Poli E, Talamonti MS, Haggerty SP, Linn JG, Ujiki MB. Rectus abdominis atrophy after ventral abdominal incisions: midline versus chevron. Hernia. 2017 08; 21(4):619-622.
    View in: PubMed
    Score: 0.170
  5. Vigneswaran Y, Linn JG, Gitelis M, Muldoon JP, Lapin B, Denham W, Talamonti M, Ujiki MB. Educating surgeons may allow for reduced intraoperative costs for inguinal herniorrhaphy. J Am Coll Surg. 2015 Jun; 220(6):1107-12.
    View in: PubMed
    Score: 0.148
  6. Brown CS, Lapin B, Wang C, Goldstein JL, Linn JG, Denham W, Haggerty SP, Talamonti MS, Howington JA, Carbray J, Ujiki MB. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Surg Endosc. 2015 Dec; 29(12):3528-34.
    View in: PubMed
    Score: 0.147
  7. Brown CS, Lapin B, Wang C, Goldstein JL, Linn JG, Denham W, Haggerty SP, Talamonti MS, Howington JA, Carbray J, Ujiki MB. Predicting regression of Barrett's esophagus: results from a retrospective cohort of 1342 patients. Surg Endosc. 2014 Oct; 28(10):2803-7.
    View in: PubMed
    Score: 0.139
  8. Yetasook AK, Leung D, Howington JA, Talamonti MS, Zhao J, Carbray JM, Ujiki MB. Laparoscopic ischemic conditioning of the stomach prior to esophagectomy. Dis Esophagus. 2013 Jul; 26(5):479-86.
    View in: PubMed
    Score: 0.123
  9. Baker MS, Bentrem DJ, Ujiki MB, Stocker S, Talamonti MS. Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy. Am J Surg. 2011 Mar; 201(3):295-9; discussion 299-300.
    View in: PubMed
    Score: 0.112
  10. Fronza JS, Bentrem DJ, Baker MS, Talamonti MS, Ujiki MB. Laparoscopic distal pancreatectomy using radiofrequency energy. Am J Surg. 2010 Mar; 199(3):401-4; discussion 404.
    View in: PubMed
    Score: 0.104
  11. Baker MS, Bentrem DJ, Ujiki MB, Stocker S, Talamonti MS. A prospective single institution comparison of peri-operative outcomes for laparoscopic and open distal pancreatectomy. Surgery. 2009 Oct; 146(4):635-43; discussion 643-5.
    View in: PubMed
    Score: 0.101
  12. Yang AD, Melstrom LG, Bentrem DJ, Ujiki MB, Wayne JD, Strouch M, Bell RH, Rao SM, Talamonti MS. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007 Oct; 142(4):529-34; discussion 534-7.
    View in: PubMed
    Score: 0.088
  13. Ujiki MB, Ding XZ, Salabat MR, Bentrem DJ, Golkar L, Milam B, Talamonti MS, Bell RH, Iwamura T, Adrian TE. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer. 2006 Dec 29; 5:76.
    View in: PubMed
    Score: 0.084
  14. Ujiki MB, Milam B, Ding XZ, Roginsky AB, Salabat MR, Talamonti MS, Bell RH, Gu W, Silverman RB, Adrian TE. A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. Biochem Biophys Res Commun. 2006 Feb 24; 340(4):1224-8.
    View in: PubMed
    Score: 0.078
  15. Gitelis M, Vigneswaran Y, Ujiki MB, Denham W, Talamonti M, Muldoon JP, Linn JG. Educating surgeons on intraoperative disposable supply costs during laparoscopic cholecystectomy: a regional health system's experience. Am J Surg. 2015 Mar; 209(3):488-92.
    View in: PubMed
    Score: 0.036
  16. Golkar L, Ding XZ, Ujiki MB, Salabat MR, Kelly DL, Scholtens D, Fought AJ, Bentrem DJ, Talamonti MS, Bell RH, Adrian TE. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res. 2007 Apr; 138(2):163-9.
    View in: PubMed
    Score: 0.021
  17. Yoshida S, Ujiki M, Ding XZ, Pelham C, Talamonti MS, Bell RH, Denham W, Adrian TE. Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Mol Cancer. 2005 Aug 05; 4:27.
    View in: PubMed
    Score: 0.019
  18. Yoshida S, Yokota T, Ujiki M, Ding XZ, Pelham C, Adrian TE, Talamonti MS, Bell RH, Denham W. Pancreatic cancer stimulates pancreatic stellate cell proliferation and TIMP-1 production through the MAP kinase pathway. Biochem Biophys Res Commun. 2004 Oct 29; 323(4):1241-5.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.